Pectus Carinatum: a non-invasive and objective measurement of severity

To date, standard methods for assessing the severity of chest wall deformities are mostly linked to X-ray and CT scans. However, the use of radiations limits their use when there is a need to monitor the development of the pathology over time. This is particularly important when dealing with patient...

Full description

Saved in:
Bibliographic Details
Published inMedical & biological engineering & computing Vol. 57; no. 8; pp. 1727 - 1735
Main Authors Servi, Michaela, Buonamici, Francesco, Furferi, Rocco, Governi, Lapo, Uccheddu, Francesca, Volpe, Yary, Leng, Stella, Facchini, Flavio, Ghionzoli, Marco, Messineo, Antonio
Format Journal Article
LanguageEnglish
Published Berlin/Heidelberg Springer Berlin Heidelberg 01.08.2019
Springer Nature B.V
Subjects
Online AccessGet full text
ISSN0140-0118
1741-0444
1741-0444
DOI10.1007/s11517-019-01993-0

Cover

Loading…
More Information
Summary:To date, standard methods for assessing the severity of chest wall deformities are mostly linked to X-ray and CT scans. However, the use of radiations limits their use when there is a need to monitor the development of the pathology over time. This is particularly important when dealing with patients suffering from Pectus Carinatum, whose treatment mainly requires the use of corrective braces and a systematic supervision. In recent years, the assessment of severity of chest deformities by means of radiation-free devices became increasingly popular but not yet adopted as standard clinical practice. The present study aims to define an objective measure by defining a severity index (named External Pectus Carinatum Index) used to monitor the course of the disease during treatment. Computed on the optical acquisition of the patients’ chest by means of an appositely devised, fast and easy-to-use, body scanner, the proposed index has been validated on a sample composed of a control group and a group of Pectus Carinatum patients. The index proved to be reliable and accurate in the characterization of the pathology, enabling the definition of a threshold that allows to distinguish the cases of patients with PC from those of healthy subjects. Graphical abstract
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ISSN:0140-0118
1741-0444
1741-0444
DOI:10.1007/s11517-019-01993-0